Data compiled by Redley Lamar · ChainSifter Intelligence
0Suppliers
9Customers
1Debt Items
8Related Chains
Source-Backed Evidence Depth
Stevanato Group S.p.A. (STVN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
11Total relationships
1Distinct source URLs
3High confidence
0.710Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Stevanato Group S.p.A. Suppliers
No suppliers on recordStevanato Group S.p.A. does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.
Stevanato Group S.p.A. Customers
Ticker
Name
Confidence
Evidence
JABIL-PACKAGING-SOLUTIONS-FLEX-PHILLIPS-MEDISIZE
JABIL-PACKAGING-SOLUTIONS-FLEX-PHILLIPS-MEDISIZE
85%
-fillable syringes), Nipro and Gerresheimer AG (bulk and ready-to-use vials and cartridges, pre-fillable syringes); • Drug Delivery Systems : SHL, Ypsomed, West Pharmaceutical Services and Becton Dic…
Reciprocal relationship from HRMY graph: Reciprocal relationship from STVN graph: t liabilities (excluding non-current advances from customers). Net working capital represents the difference between …
t liabilities (excluding non-current advances from customers). Net working capital represents the difference between current assets and current liabilities, excluding (i) current financial assets oth…
DENMARK-THE-GROUP
DENMARK-THE-GROUP
62%
. At December 31, 2025, the Group operated 13 manufacturing facilities, consisting of: (i) ten plants dedicated to the manufacturing and assembly of bio‑pharma and healthcare products (located in Ita…
ECL-THE-GROUP
ECL-THE-GROUP
62%
r not to exercise the option to renew or terminate the lease. That is, it considers all relevant factors that create an economic incentive for it to exercise either the renewal or termination. Expect…
GERRESHEIMER-AG
GERRESHEIMER-AG
62%
-fillable syringes), Nipro and Gerresheimer AG (bulk and ready-to-use vials and cartridges, pre-fillable syringes); • Drug Delivery Systems : SHL, Ypsomed, West Pharmaceutical Services and Becton Dic…
IQVIA-LTD
IQVIA-LTD
62%
opharmaceutical and Diagnostic Solutions, and Engineering), combined with our global footprint, allow us to sell products and provide services in approximately 65 countries worldwide which we achieve…
LEASES-THE-GROUP
LEASES-THE-GROUP
62%
stomers Contract liabilities and advances from customers are as follows: At December 31, At December 31, 2025 2024 (EUR thousand) Contract Liabilities 10,414 16,545 Advances from customers 132,273 60…
PHILLIPS-MEDISIZE-GERRESHEIMER-AG
PHILLIPS-MEDISIZE-GERRESHEIMER-AG
62%
, Phillips Medisize, Gerresheimer AG, and West Pharmaceutical Services; and, • Engineering : Syntegon, Korber, ATS, IMA, Brevetti CEA and Mikron. Marketing We market and sell our products both direct…
Stevanato Group S.p.A. Debt Obligations
Instrument
Description
Confidence
Evidence
STVN-DEBT
Debt stack $525.3M
90%
Market cache reports total debt of $525.3M.
Stevanato Group S.p.A. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Stevanato Group S.p.A..
Stevanato Group S.p.A. Ownership
Holder
Name
Confidence
Evidence
STVN-OWNER-CONESTOGA-CAPITAL-ADVISORS-LLC
Conestoga Capital Advisors, LLC
90%
13F overlay lists Conestoga Capital Advisors, LLC as top holder; 135 tracked holders.
Stevanato Group S.p.A. Extended Supply Chain Network
